APA (7th ed.) Citation

Teuschl, Y., Bancher, C., Brainin, M., Dachenhausen, A., Matz, K., & Pinter, M. M. (2022). COVID-19-related delays of botulinum toxin injections have a negative impact on the quality of life of patients with dystonia and spasticity. Journal of Neural Transmission: Translational Neuroscience, Neurology and Preclinical Neurological Studies, Psychiatry and Preclinical Psychiatric Studies, 129(1), 49-53. https://doi.org/10.1007/s00702-021-02430-z

Chicago Style (17th ed.) Citation

Teuschl, Yvonne, Christian Bancher, Michael Brainin, Alexandra Dachenhausen, Karl Matz, and Michaela M. Pinter. "COVID-19-related Delays of Botulinum Toxin Injections Have a Negative Impact on the Quality of Life of Patients with Dystonia and Spasticity." Journal of Neural Transmission: Translational Neuroscience, Neurology and Preclinical Neurological Studies, Psychiatry and Preclinical Psychiatric Studies 129, no. 1 (2022): 49-53. https://doi.org/10.1007/s00702-021-02430-z.

MLA (9th ed.) Citation

Teuschl, Yvonne, et al. "COVID-19-related Delays of Botulinum Toxin Injections Have a Negative Impact on the Quality of Life of Patients with Dystonia and Spasticity." Journal of Neural Transmission: Translational Neuroscience, Neurology and Preclinical Neurological Studies, Psychiatry and Preclinical Psychiatric Studies, vol. 129, no. 1, 2022, pp. 49-53, https://doi.org/10.1007/s00702-021-02430-z.